News

Welcome! Here you can find novelties and news about Biofarm.



Biofarm records a net profit of 65.7 million lei in the first nine months of the year, up 20%

Biofarm recorded a turnover of 208.9 million lei, up 17%, and a net profit of 65.7 million lei, up 20%, compared to the same perio...

Biofarm recorded a turnover of 208.9 million lei, up 17%, and a net profit of 65.7 million lei, up 20%, compared to the same period last year. At the same time, Biofarm recorded EBITDA of 89.4 million lei, up 18% compared to the first nine months of the previous year.

Read more

Biofarm records a net profit of 43.6 million RON in the first six months of the year, up 20%

Biofarm reports significant increases in the first half of the year compared to the same period of 2021: turnover is increasing by...

Read more

Biofarm aims to reach a 16% increase in turnover for 2022

Biofarm estimates a 16% increase in turnover this year, after recording a value of 239 million RON and an EBITDA of approximately ...

Read more

Corporate Governance

SHARE PRICE / INDEX

BIO

29 November 2022

0.5840 lei

Read more

Biofarm registers a net profit of 60 million lei in 2021, up by 11% compared to 2020

Biofarm reports positive evolution for the preliminary results of 2021: turnover of 239 million lei and a net profit of 60 million...

Read more

Biofarm registers a 54.8million RON net profit in the first nine months of the year, with an increase of 20% compared to the same period of 2020

Biofarm reports significant increases for the first nine months of the year compared to the same period of 2020. Biofarm registere...

Read more

Biofarm celebrates 100 years of uninterrupted activity and inaugurates one of the most modern drug factories in Romania following an investment of over 35 million euros

Biofarm inaugurated a new production and testing facility in Bucharest, in which over 35 million euros were invested.

Read more

Four years of continuous growth for Biofarm. In the centennial year, the company continues to invest and expand in foreign markets

Biofarm registered between 2017 and 2020, an aggregate increase of 8% in turnover and 15% in profit, thus managing to strengthen i...

Read more

Biofarm concludes the first semester of 2021 with a net profit of 36.4 million RON

Biofarm ended the first half of this year with a net profit of 36.4 million RON. The number symbolises an increase of approximate...

Read more

Biofarm ends the first quarter of 2021 with a net profit of 22.5 million lei and significant increases in the Consumer Healthcare segment

Biofarm ended the first quarter of this year with a net profit of 22.5 million lei, increasing by over 21% compared to the same p...

Read more

Biofarm will make investments of 47.4 million lei in 2021

Biofarm will make investments of over 47 million lei in 2021. These aim to equip the new production unit, but also the modernizati...

Read more

Biofarm Marks The Centenary With Its Anniversary Campaign "100 years investing in the future"

Biofarm celebrates its centenary this year and marks the event through an anniversary campaign with the message "100 years investi...

Read more

Biofarm targets a 15% turnover increase in 2021

The Romanian drug manufacturer targets a 15% turnover increase in 2021. The company plans to obtain a value of sales revenues of o...

Read more

BIOFARM turnover grows 8% in 2020 compared to 2019

The result is due to the sustained efforts of the company to maintain investments at a competitive level throughout 2020, but also...

Read more

Biofarm responds to the challenges brought by the wave of diseases with COVID 19 according to the principles and values assumed by the company

Biofarm employees remain on the front line to be able to provide Romanian patients with the treatments they need.

Read more

Cătălin Vicol (Biofarm): „România are șansa acum să renască din punct de vedere economic și poate s-o facă dacă își ascultă cu atenție oamenii”

Forbes România a invitat comunitatea de business din România să răspundă la cele mai importante chestiuni ale momentului în ...

Read more

Cătălin Vicol, Biofarm: Ne dorim să intensificăm activitatea de export, în perioada viitoare

Producătorul de medicamente Biofarm (BIO) țintește să intensifice exporturile, care în prezent reprezintă 2% din cifra de af...

Read more

Biofarm donează 1 milion de lei pentru lupta împotriva Covid-19

București, 15.04.2020 – Biofarm se alătură luptei de combatere a noului Coronavirus în România printr-o donație de 1 milio...

Read more

CEO Biofarm: Provocările acestui an sunt potenţiala majorare a preţurilor la materii prime şi insuficienţa forţei de muncă calificată

Producătorul român de medicamente Biofarm (simbol bursier BIO) şi-a planificat pentru acest an creşterea cotei de piaţă şi ...

Read more

Corporate Governance

SHARE PRICE / INDEX

BIO

29 November 2022

0.5840 lei

Read more